Medcomtech, S.A.

BME:MED Stock Report

Market Cap: €8.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Medcomtech Balance Sheet Health

Financial Health criteria checks 2/6

Medcomtech has a total shareholder equity of €256.8K and total debt of €18.2M, which brings its debt-to-equity ratio to 7076.7%. Its total assets and total liabilities are €30.1M and €29.8M respectively. Medcomtech's EBIT is €1.0M making its interest coverage ratio 0.8. It has cash and short-term investments of €2.0M.

Key information

7,076.69%

Debt to equity ratio

€18.17m

Debt

Interest coverage ratio0.8x
Cash€1.99m
Equity€256.76k
Total liabilities€29.82m
Total assets€30.08m

Recent financial health updates

Analysis Article • May 17

Here's Why Medcomtech (BME:MED) Can Afford Some Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Recent updates

Analysis Article • Oct 18

Returns Are Gaining Momentum At Medcomtech (BME:MED)

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Analysis Article • Aug 26

Many Still Looking Away From Medcomtech, S.A. (BME:MED)

Medcomtech, S.A.'s ( BME:MED ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...
Analysis Article • Mar 21

Returns At Medcomtech (BME:MED) Are On The Way Up

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Dec 06

Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Aug 16

Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Analysis Article • Apr 09

Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Analysis Article • May 17

Here's Why Medcomtech (BME:MED) Can Afford Some Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Nov 30

Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 8.3% over the past three months, it is easy to disregard Medcomtech (BME:MED). But if you pay...

Financial Position Analysis

Short Term Liabilities: MED's short term assets (€22.1M) exceed its short term liabilities (€13.8M).

Long Term Liabilities: MED's short term assets (€22.1M) exceed its long term liabilities (€16.0M).

Debt to Equity History and Analysis

Debt Level: MED's net debt to equity ratio (6300.1%) is considered high.

Reducing Debt: MED's debt to equity ratio has increased from 928.9% to 7076.7% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if MED has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MED has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/13 19:48
End of Day Share Price 2024/01/15 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medcomtech, S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael Thomas CooperEdison Investment Research